Lakefront Biotherapeutics (LKFT) Total Current Liabilities (2013 - 2026)
Lakefront Biotherapeutics (LKFT) recorded Total Current Liabilities of $117.57 million in the quarter ended Mar 31, 2026, down 74.4% from $459.72 million a year earlier and down 33.9% from the prior quarter.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Total Current Liabilities (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Lakefront Biotherapeutics reported Total Current Liabilities of $172.71 million, down 52.4% from the prior year.
- Annual Total Current Liabilities has declined for five straight years, with a five-year compound annual growth rate of -81.1% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Total Current Liabilities came in at $362.67 million in the year ended Dec 31, 2024 (-21.3%), $460.74 million in the year ended Dec 31, 2023 (-99.9%), $550.73 billion in the year ended Dec 31, 2022 (-17.8%) and $670.36 billion in the year ended Dec 31, 2021 (-7.6%).
- The figure for the quarter ended Mar 31, 2026 is the lowest quarterly Total Current Liabilities since the quarter ended Dec 31, 2016.
- On a year-over-year basis, Total Current Liabilities rose in two of the last six quarters, with an average decline of 24.2%.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 11.1% in the quarter ended Sep 30, 2025, against a decline of 99.9% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $177.94 million (quarter ended Dec 31, 2025), $428.53 million (quarter ended Sep 30, 2025) and $456.13 million (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Lakefront Biotherapeutics | 1.97 Bn | 1.97 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 117.57 Mn |
| Dec 31, 2025 | 177.94 Mn |
| Sep 30, 2025 | 428.53 Mn |
| Jun 30, 2025 | 456.13 Mn |
| Mar 31, 2025 | 459.72 Mn |
| Dec 31, 2024 | 358.07 Mn |
| Sep 30, 2024 | 385.73 Mn |
| Mar 31, 2024 | 415.22 Mn |
| Dec 31, 2023 | 460.74 Mn |
| Sep 30, 2023 | 483.37 Mn |
| Mar 31, 2023 | 561.25 Mn |
| Dec 31, 2022 | 533.12 Bn |
| Mar 31, 2022 | 631.76 Mn |
| Dec 31, 2021 | 648.03 Bn |
| Jun 30, 2021 | 694.85 Mn |
| Dec 31, 2020 | 757.43 Bn |
| Jun 30, 2020 | 681.29 Mn |
| Mar 31, 2020 | 687.34 Mn |
| Dec 31, 2019 | 632.91 Mn |
| Sep 30, 2019 | 702.47 Mn |
API Access
Lakefront Biotherapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();